🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What are the implications for CAR-T cell therapy for autoimmune diseases? 1- we need safety switches 2- we need targeted editing approaches, not just random integration 3- we need to favor therapies that are rejected (e.g., most allogenic CAR-T cells get rejected) All exist.

Don't miss out: paflar.org/paflar-annual-…

Don't miss out: paflar.org/paflar-annual-…

👉Multiethnic cohort of infants born to anti-Ro antibody positive mothers showed no significant difference in the prevalence of allergic, neurodevelopmental, or autoimmune diseases. acrjournals.onlinelibrary.wiley.com/doi/10.1002/ac…

👋Hey CARRA members and friends, we can't wait to see you this week for #CARRA2025! Please use #CARRA2025 in your posts and also to follow along with the Annual Scientific Meeting.

Share your ideas & expertise at #PRSYM26 by submitting a session proposal. #PRSYM26 will address clinical innovation & cutting-edge research in #pedsrheum. Proposals & speaker suggestions due by April 10. Details → acr.tw/4jgKs73

Looking for the latest updates on treatments and disparities for patients with systemic lupus erythematosus and lupus nephritis? Join us at AWIR 2025 to learn from Maria Dall’Era, MD, Jean S. Engleman Distinguished Professor of Medicine and Chief of the Division of

So exciting! #PaediatricRheumatologyRocks #TerrificTanzania #PAFLARCongress2026 #SpreadTheWord PAFLAR AFRICA EULAR American College of Rheumatology APLAR Panlar Kenya Paediatric Association World Health Organization (WHO) Francis Furia Paediatric Association of Tanzania

No Extra Cancer Recurrence Risk with Biologics in RA Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater likelihood of cancer relapse when they were treated with biologic agents, compared with conventional

When passion meets purpose, history is made🌍✨ From groundbreaking science to unstoppable advocacy, the PAFLAR AFRICA Congress in Nigeria—led by our inspiring new President, @Dr. Ayodele Faleye 🇳🇬—was a powerful call to action💥 We’re not just treating—we’re transforming futures

4/ 💊 Class III/IV ± V LN: Conditionally recommend triple therapy: Pulse IV steroids → oral taper (≤0.5 mg/kg/day, max 40 mg) One of: a) MPAA + belimumab b) MPAA + CNI

5/ 💊 Class V LN (Pure Membranous): If proteinuria ≥1g/g: Use triple therapy (GC + MPAA + CNI) If <1g/g: GC + MPAA, AZA, or CNI > no therapy Less data here—treatment is tailored.

There's still time to join us this summer in Salt Lake City, UT! We hope to see you at JA Family Summit in July! arthr.org/3DXaFbr

We thank our Founding President and Immediate Past President, Dr. Angela for your visionary leadership and unwavering dedication. You laid the foundation, steered the mission, and inspired a movement. PAFLAR stands stronger today because of your legacy. #PAFLAR #Leadership

⁦Rheumatology Research Foundation⁩ rocking my new RRF swag to the #lupus25 meeting!

What a DAY! 💥Thank you for an unforgettable start to #Lupus2025 here in Toronto. We’ll see you bright and early tomorrow for Day 2 — full of science, stories & connection. 💜 Keep tagging your highlights with #Lupus2025 📸

The Fellowship Training Award supports the training of promising rheumatology fellows to ensure a more robust, highly trained workforce is available to meet the needs of people with rheumatic diseases. Apply by 5 PM ET on June 2, 2025! rheumresearch.org/education-and-…

Steroids in Lupus Nephritis: No Free Lunch Hello, I'm Mike Putman, I'm Assistant Professor of Medicine at the Medical College of Wisconsin in Milwaukee, Wisconsin. Today I'm here to talk with you about steroids in lupus nephritis. The impetus for this is the 2024 ACR guideline

In this photo the happiness of being part of this wonderful Congress with people who speak the same language (lupus, not Italian 🤣) and our contribution in studying #cognitivedysfunction in #lupus #brainfog #lupus2025 Matteo Piga

From simulations to curricula, recipients of the Clinician Scholar Educator Award develop valuable tools and methods to train the next generation of rheumatologists. You can see examples of the tools developed from these awards online: rheumresearch.org/tools-from-cli… The deadline to